BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 9636749)

  • 1. [Prognostic factors and predictive signs of malignancy in adult dermatomyositis].
    Gallais V; Crickx B; Belaich S
    Ann Dermatol Venereol; 1996; 123(11):722-6. PubMed ID: 9636749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic factors and predictive signs of malignancy in adult dermatomyositis. A study of 32 cases.
    Basset-Seguin N; Roujeau JC; Gherardi R; Guillaume JC; Revuz J; Touraine R
    Arch Dermatol; 1990 May; 126(5):633-7. PubMed ID: 2334184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cutaneous necrosis is predictive of cancer in adult dermatomyositis].
    Burnouf M; Mahé E; Verpillat P; Descamps V; Lebrun-Vignes B; Picard-Dahan C; Belaïch S; Crickx B
    Ann Dermatol Venereol; 2003 Mar; 130(3):313-6. PubMed ID: 12746665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of erythrocyte sedimentation rate as tumor marker in cancer associated dermatomyositis.
    Amerio P; Girardelli CR; Proietto G; Forleo P; Cerritelli L; Feliciani C; Colonna L; Teofoli P; Amerio P; Puddu P; Abeni D
    Eur J Dermatol; 2002; 12(2):165-9. PubMed ID: 11872415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting factors of interstitial lung disease in dermatomyositis and polymyositis.
    Chen YJ; Wu CY; Shen JL
    Acta Derm Venereol; 2007; 87(1):33-8. PubMed ID: 17225013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dermatomyositis and malignancy: a retrospective study of 115 cases.
    Zhang W; Jiang SP; Huang L
    Eur Rev Med Pharmacol Sci; 2009; 13(2):77-80. PubMed ID: 19499841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Erythroderma and multiple cutaneous necrosis revealing a dermatomyositis].
    Maruani A; Armingaud P; Nseir A; Luthier F; Estève E
    Ann Dermatol Venereol; 2003 Mar; 130(3):353-6. PubMed ID: 12746674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymyositis and dermatomyositis: short term and longterm outcome, and predictive factors of prognosis.
    Marie I; Hachulla E; Hatron PY; Hellot MF; Levesque H; Devulder B; Courtois H
    J Rheumatol; 2001 Oct; 28(10):2230-7. PubMed ID: 11669162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship of dermatomyositis and polymyositis to internal malignancy.
    Callen JP; Hyla JF; Bole GG; Kay DR
    Arch Dermatol; 1980 Mar; 116(3):295-8. PubMed ID: 7369745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dermatomyositis and polymyositis associated with malignancy: a 21-year retrospective study.
    András C; Ponyi A; Constantin T; Csiki Z; Szekanecz E; Szodoray P; Dankó K
    J Rheumatol; 2008 Mar; 35(3):438-44. PubMed ID: 18203322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer-associated myositis: clinical features and prognostic signs.
    Ponyi A; Constantin T; Garami M; András C; Tállai B; Váncsa A; Gergely L; Dankó K
    Ann N Y Acad Sci; 2005 Jun; 1051():64-71. PubMed ID: 16126945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary involvement in polymyositis and in dermatomyositis.
    Marie I; Hatron PY; Hachulla E; Wallaert B; Michon-Pasturel U; Devulder B
    J Rheumatol; 1998 Jul; 25(7):1336-43. PubMed ID: 9676766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Newly diagnosed dermatomyositis in the elderly as predictor of malignancy.
    de Souza FH; Shinjo SK
    Rev Bras Reumatol; 2012 Oct; 52(5):713-21. PubMed ID: 23090371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Biochemical monitoring of prostate cancer treated exclusively by radiotherapy: prognostic value of pretreatment PSA, PSA nadir and PSA half-life].
    Chautard D; Cellier P; Dalifard I; Pabot du Chatelard P; Chaussis F; Vielle B; Soret JY; Passagot J; Courte C; Daver A
    Prog Urol; 2002 Jun; 12(3):421-8. PubMed ID: 12189749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Myositis associated with tumors].
    András C; Ponyi A; Constantin T; Csiki Z; Illés A; Szegedi G; Dankó K
    Magy Onkol; 2002; 46(3):253-9. PubMed ID: 12368921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical course of idiopathic inflammatory myopathies: complications, survival and prognostic factors].
    Miró O; Laguno M; Alonso JR; Casademont J; Herrero C; Selva A; Urbano-Márquez A; Grau JM
    Med Clin (Barc); 1999 Apr; 112(14):521-6. PubMed ID: 10363237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Juvenile dermatomyositis in Thai children.
    Singalavanija S; Liamsuwan S; Limpongsanurak W; Raungsuwan S
    J Med Assoc Thai; 2001 Nov; 84(11):1527-33. PubMed ID: 11853294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination antimalarials in the treatment of cutaneous dermatomyositis: a retrospective study.
    Ang GC; Werth VP
    Arch Dermatol; 2005 Jul; 141(7):855-9. PubMed ID: 16027300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pulmonary lesions in dermatomyositis. A retrospective study of 4 cases].
    Job-Deslandre C; Menkes CJ; Delrieu F; Delbarre F
    Nouv Presse Med; 1982 Nov; 11(45):3317-9. PubMed ID: 7155832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence, risk factors, and severity of herpesvirus infections in a cohort of 121 patients with primary dermatomyositis and dermatomyositis associated with a malignant neoplasm.
    Fardet L; Rybojad M; Gain M; Kettaneh A; Cherin P; Bachelez H; Dubertret L; Lebbe C; Morel P; Dupuy A
    Arch Dermatol; 2009 Aug; 145(8):889-93. PubMed ID: 19687419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.